检索结果 - Katelyn Brown

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program

    Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program 由 Ildiko Lingvay, Ofri Mosenzon, Katelyn Brown, Xuewei Cui, Ciara O’Neill, Laura Fernández Landó, Hiren Patel

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: <scp>H</scp>igher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide

    Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: <scp>H</scp>igher adherence and persistence with dulaglutide co... 由 Carlos Alatorre, Laura Fernández Landó, Maria Yu, Katelyn Brown, Leslie Montejano, Paul Juneau, Reema Mody, Ralph Swindle

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes 由 Juan P. Frías, Melanie J. Davies, Julio Rosenstock, Federico C. Pérez Manghi, Laura Fernández Landó, Brandon K. Bergman, Bing Liu, Xuewei Cui, Katelyn Brown

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: